WF_1170x120_6-19-20

L’Oréal

Garnier USA delivers hand sanitizers to frontline employees

Garnier USA delivers hand sanitizers to frontline employees

NEW YORK —Garnier USA will produce 2 million units of 4-fluid-ounce hand sanitizers at their Franklin, N.J., manufacturing facility, and will begin distribution of them this month free of charge to frontline retail employees in the most affected areas of the country. “We are very grateful for the hard work of essential employees and the service they are bringing

CeraVe debuts facial serum and cleanser for acne-prone skin

CeraVe debuts facial serum and cleanser for acne-prone skin

NEW YORK — L’Oréal’s CeraVe brand has introduced Acne Foaming Cream Cleanser with benzoyl peroxide and Resurfacing Retinol Serum as the two latest additions to its portfolio of therapeutic skin care products developed with dermatologists to meet the needs of acne-prone skin. “Acne is a common skin concern that affects millions of people both physically

CeraVe launches Hyaluronic Acid Serum and products for diabetic skin

CeraVe launches Hyaluronic Acid Serum and products for diabetic skin

NEW YORK — CeraVe, a skin care brand owned by L’Oréal, has expanded its portfolio of therapeutic skin care products to include a Hydrating Hyaluronic Acid Serum and a Diabetics’ Dry Skin Relief line, which includes a moisturizing cream, hand and foot cream, and a cleansing wash. The Diabetics’ Dry Skin Relief line was developed to address the specific

Revlon tabs L’Oréal veteran to lead Elizabeth Arden

Revlon tabs L’Oréal veteran to lead Elizabeth Arden

NEW YORK — Former L’Oréal executive Serge Jureidini is joining Revlon Inc. as president of Elizabeth Arden & Fragrances. Revlon said Tuesday that Jureidini will take over from JuE Wong, president of Elizabeth Arden, who is leaving the company effective March 31, and George Cleary, president of global fragrances for Elizabeth Arden, who has joined

L’Oréal buys CeraVe, AcneFree, Ambi brands from Valeant

L’Oréal buys CeraVe, AcneFree, Ambi brands from Valeant

CLICHY, N.Y. — L’Oréal plans to acquire the CeraVe, AcneFree and Ambi skin care brands from Valeant Pharmaceuticals International Inc. for $1.3 billion in cash. Plans call for CeraVe, AcneFree and Ambi to become part of the L’Oréal Active Cosmetics Division, which includes the La Roche-Posay, Vichy and SkinCeuticals brands developed with and endorsed by